Results 91 to 93 of about 308,877 (93)

Long-term results with immediate androgen suppression and external irradiation in patients with locally advanced prostate cancer (an EORTC study): a phase III randomised trial.

The Lancet, 2002
M. Bolla, L. Collette, L. Blank, P. Warde, J. Dubois, R. Mirimanoff, G. Storme, J. Bernier, A. Kuten, C. Sternberg, J. Mattelaer, J. L. Torecilla, J. Pfeffer, C. L. Cutajar, A. Zurlo, M. Piérart   +15 more
semanticscholar   +1 more source

In vivo amplification of the androgen receptor gene and progression of human prostate cancer

Nature Genetics, 1995
T. Visakorpi, E. Hyytinen, P. Koivisto, M. Tanner, R. Keinänen, C. Palmberg, A. Palotie, T. Tammela, J. Isola, O. Kallioniemi   +9 more
semanticscholar   +1 more source

Persistent DDT metabolite p,p'–DDE is a potent androgen receptor antagonist

Nature, 1995
W. Kelce, Christy R. Stone, S. Laws, L. Gray, J. A. Kemppainen, E. M. Wilson   +5 more
semanticscholar   +1 more source